{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:49:14Z","timestamp":1764402554980},"reference-count":26,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.vaccine.2012.05.064","type":"journal-article","created":{"date-parts":[[2012,6,10]],"date-time":"2012-06-10T10:00:10Z","timestamp":1339322410000},"page":"5270-5277","source":"Crossref","is-referenced-by-count":6,"title":["Safety and immunogenicity of fully liquid DTaP5-IPV-Hib pediatric combination vaccine (Pediacel\u00ae) compared to DTaP3-HBV-IPV\/Hib (Infanrix\u00ae Hexa) when coadministered with heptavalent pneumococcal conjugate vaccine (PCV7) as a booster at 11\u201318 months of age: A phase III, modified double-blind, randomized, controlled, multicenter study"],"prefix":"10.1016","volume":"30","author":[{"given":"Reinhard","family":"Berner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Boisnard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"Mwawasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"May (18)","key":"10.1016\/j.vaccine.2012.05.064_bib0005","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1016\/j.vaccine.2006.02.018","volume":"24","author":"Kitchin","year":"2006","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.05.064_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/adc.2005.076109","article-title":"Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus\u2013Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age","volume":"92","author":"Kitchin","year":"2007","journal-title":"Arch Dis Child"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.05.064_bib0015","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/adc.2004.052720","article-title":"DT5aP-Hib-IPV and MCC vaccines: preterm infants\u2019 response to accelerated immunisation","volume":"90","author":"Slack","year":"2005","journal-title":"Arch Dis Child"},{"issue":"October (43)","key":"10.1016\/j.vaccine.2012.05.064_bib0020","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1016\/j.vaccine.2011.07.078","volume":"29","author":"Grimprel","year":"2011","journal-title":"Vaccine"},{"issue":"July (4)","key":"10.1016\/j.vaccine.2012.05.064_bib0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1155\/2007\/289842","article-title":"Safety and immunogenicity of a fully liquid vaccine containing five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis\u2013Haemophilus influenzae type b conjugate vaccines administered at two, four, six and 18 months of age","volume":"18","author":"Gold","year":"2007","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"April (6)","key":"10.1016\/j.vaccine.2012.05.064_bib0030","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0264-410X(97)00241-7","article-title":"Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis\u2013Haemophilus B conjugate vaccine administered to infants at two, four and six months of age","volume":"16","author":"Mills","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.05.064_bib0035","series-title":"11th international congress on infectious diseases","article-title":"Immunogenicity and safety of a fully liquid DTaP-IPV-Hib vaccine with full primary IPV or sequential IPV-OPV in Mexican infants [Poster 18. 010]","author":"Castaneda","year":"2004"},{"key":"10.1016\/j.vaccine.2012.05.064_bib0040","series-title":"24th international congress of pediatrics","article-title":"Enhanced inactivated poliovaccine (IPV) in a fully liquid pentavalent DTaP-IPV-PRP-T combination: immunogenicity and safety in Mexican infants [Poster 346]","author":"Castaneda","year":"2004"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2012.05.064_bib0045","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ijid.2007.01.006","article-title":"One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine","volume":"11","author":"Lin","year":"2007","journal-title":"Int J Infect Dis"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2012.05.064_bib0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijid.2005.10.014","article-title":"A fully liquid diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis\u2013Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants","volume":"11","author":"Lin","year":"2007","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.05.064_bib0055","series-title":"3rd world congress of pediatric infectious diseases \u2013 World Society for Pediatric Infectious Diseases","article-title":"Immunogenicity and safety of a fully liquid DTaP-IPV-HiB vaccine in infants at 6, 10, and 14 weeks of age (EPI schedule) [Poster 59]","author":"Capeding","year":"2002"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.05.064_bib0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.inf.0000148923.46453.48","article-title":"Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus\u2013Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine","volume":"24","author":"Tichmann-Schumann","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.05.064_bib0065","series-title":"43rd interscience conference on antimicrobial agents and chemotherapy","article-title":"Immunogenicity and safety of a fourth (booster) dose of a 7-valent pneumococcal conjugate vaccine (7VPnC) co-administered with a DTaPIPV-HBV\/Hib vaccine","author":"Schmitt","year":"2003"},{"key":"10.1016\/j.vaccine.2012.05.064_bib0070","unstructured":"U.S. National Institutes of Health (NIH) Website. Study to compare booster vaccination with Pediacel\u00ae to Infanrix\u00ae Hexa when both are co-administered with Prevenar\u00ae. Available from: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00355654?term=A5I19&rank=1 [cited 2011 August 15]."},{"key":"10.1016\/j.vaccine.2012.05.064_bib0075","unstructured":"Prevenar [summary of product characteristics]. Louvain-la-Neuve, Belgium: Wyeth Lederle Vaccines S.A.; 2009. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000323\/WC500041563.pdf [cited 2011 April 22]."},{"key":"10.1016\/j.vaccine.2012.05.064_bib0080","unstructured":"European Medicines Agency (EMEA). Note for guidance on clinical safety data management: definitions and standards for expedited reporting (CPMP\/ICH.377\/395); 1994. Available from: http:\/\/www.emea.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500002749.pdf [cited 2012 May 14]."},{"key":"10.1016\/j.vaccine.2012.05.064_bib0085","series-title":"Vaccines","author":"Plotkin","year":"2008"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2012.05.064_bib0090","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2012.05.064_bib0095","series-title":"Introduction to mathematical statistics","author":"Hogg","year":"1978"},{"key":"10.1016\/j.vaccine.2012.05.064_bib0100","series-title":"Modelling binary data","author":"Collett","year":"1991"},{"issue":"September (25\u201326)","key":"10.1016\/j.vaccine.2012.05.064_bib0105","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1016\/S0264-410X(03)00389-X","article-title":"The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine","volume":"21","author":"Schmitt","year":"2003","journal-title":"Vaccine"},{"issue":"January (5\u20136)","key":"10.1016\/j.vaccine.2012.05.064_bib0110","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.vaccine.2003.09.007","article-title":"Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation","volume":"22","author":"Marcy","year":"2004","journal-title":"Vaccine"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2012.05.064_bib0115","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1086\/375820","article-title":"Extensive limb swelling after immunization: reports to the Vaccine Adverse Event Reporting System","volume":"37","author":"Woo","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2012.05.064_bib0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/422454","article-title":"Fever after immunization: current concepts and improved future scientific understanding","volume":"39","author":"Kohl","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2012.05.064_bib0125","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1045-1870(03)00033-5","article-title":"Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines","volume":"14","author":"Rennels","year":"2003","journal-title":"Semin Pediatr Infect Dis"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.05.064_bib0130","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/INF.0b013e31816591f7","article-title":"Safety of a fifth dose of diphtheria and tetanus toxoid and acellular pertussis vaccine in children experiencing extensive, local reactions to the fourth dose","volume":"27","author":"Rennels","year":"2008","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1200816X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1200816X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T17:37:24Z","timestamp":1561829844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1200816X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":26,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0264410X1200816X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.05.064","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}